Streetbeat News

Analyst Ratings

WELL

Keybanc analyst Todd Thomas maintains an Overweight rating on Welltower (NYSE:WELL) and raises the price target from $80 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:05 pm

ENPH

JP Morgan analyst Mark Strouse has maintained an Overweight rating on Enphase Energy (NASDAQ:ENPH) but lowered the price target from $169 to $155.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:03 pm

BBY

FSLR

FTNT

GPK

NFLX

NTRS

PRLD

PXD

STGW

UAL

Top Wall Street analysts have updated their outlooks on several stocks. Pioneer Natural Resources, Prelude Therapeutics, Graphic Packaging Holding, Fortinet, First Solar, Best Buy, Northern Trust, Netflix, United Airlines, and Stagwell have all seen changes in their price targets and ratings.

Portfolio Pulse from Lisa Levin

October 19, 2023 | 12:03 pm

HWM

Keybanc analyst Philip Gibbs maintains an Overweight rating on Howmet Aerospace (NYSE:HWM) but lowers the price target from $52 to $50.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:03 pm

ATI

Keybanc analyst Philip Gibbs maintains an Overweight rating on ATI (NYSE:ATI) but lowers the price target from $49 to $48.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:01 pm

APTV

Over the past 3 months, 11 analysts have published their opinion on Aptiv (NYSE:APTV) stock. The company has an average price target of $135.64, an increase of 3.05% from the previous average price target of $131.62. The majority of the ratings are bullish or somewhat bullish.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 12:01 pm

CDNS

Analysts have provided bullish ratings for Cadence Design Sys (NASDAQ:CDNS) within the last quarter, with an average price target of $261.88, implying an upside from the current price of $246.0. The current average has increased by 0.72% from the previous average price target of $260.00.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 12:00 pm

PRLD

Over the past 3 months, 4 analysts have published their opinion on Prelude Therapeutics (NASDAQ:PRLD) stock. The company has an average price target of $9.5, representing a 16.15% decrease from the previous average price target of $11.33. Two analysts have given bullish ratings, while two remained indifferent.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 12:00 pm

SOFI

In the last quarter, SoFi Techs (NASDAQ:SOFI) received 5 bullish, 5 indifferent, and 1 somewhat bearish rating from analysts. The average price target is $10.91, indicating an upside from the current price of $7.71. This average has increased by 7.81% from the previous target of $10.12.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 12:00 pm

XYL

Analysts have provided various ratings for Xylem (NYSE:XYL) within the last quarter, with an average price target of $117.5, implying an upside from the current price of $91.06. This current average represents a 8.91% decrease from the previous average price target of $129.00.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 12:00 pm